Drag Force Measurements of Vegetation Elements

Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchiv

Impacts of management practices on bioenergy feedstock yield and economic feasibility on Conservation Reserve Program grasslands

Citation: Anderson, E. K., Aberle, E., Chen, C., Egenolf, J., Harmoney, K., Kakani, V. G., . . . Lee, D. (2016). Impacts of management practices on bioenergy feedstock yield and economic feasibility on Conservation Reserve Program grasslands. GCB Bioenergy. doi:10.1111/gcbb.12328Perennial grass mixtures planted on Conservation Reserve Program (CRP) land are a potential source of dedicated bioenergy feedstock. Long-term nitrogen (N) and harvest management are critical factors for maximizing biomass yield while maintaining the longevity of grass stands. A six-year farm-scale study was conducted to understand the impact of weather variability on biomass yield, determine optimal N fertilization and harvest timing management practices for sustainable biomass production, and estimate economic viability at six CRP sites in the United States. Precipitation during the growing season was a critical factor for annual biomass production across all regions, and annual biomass production was severely reduced when growing season precipitation was below 50% of average. The N rate of 112 kg ha-1 produced the highest biomass yield at each location. Harvest timing resulting in the highest biomass yield was site-specific and was a factor of predominant grass type, seasonal precipitation, and the number of harvests taken per year. The use of N fertilizer for yield enhancement unambiguously increased the cost of biomass regardless of the harvest timing for all six sites. The breakeven price of biomass at the farmgate ranged from $37 to$311 Mg-1 depending on the rate of N application, timing of harvesting, and location when foregone opportunity costs were not considered. Breakeven prices ranged from $69 to$526 Mg-1 when the loss of CRP land rental payments was included as an opportunity cost. Annual cost of the CRP to the federal government could be reduced by over 8% in the states included in this study; however, this would require the biomass price to be much higher than in the case where the landowner receives the CRP land rent. This field research demonstrated the importance of long-term, farm-scale research for accurate estimation of biomass feedstock production and economic viability from perennial grasslands. © 2016 John Wiley & Sons Ltd

Recent results in nuclear astrophysics at the n_TOF facility at CERN

The neutron time of flight (n_TOF) facility at CERN is a spallation source characterized by a white neutron spectrum. The innovative features of the facility, in the two experimental areas, (20 m and 185 m), allow for an accurate determination of the neutron cross section for radioactive samples or for isotopes with small neutron capture cross section, of interest for Nuclear Astrophysics. The recent results obtained at n_TOF facility are presented

Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif

APOBEC3B is a newly identified source of mutation in many cancers, including breast, head/neck, lung, bladder, cervical, and ovarian. APOBEC3B is a member of the APOBEC3 family of enzymes that deaminate DNA cytosine to produce the promutagenic lesion, uracil. Several APOBEC3 family members function to restrict virus replication. For instance, APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H combine to restrict HIV-1 in human lymphocytes. HIV-1 counteracts these APOBEC3s with the viral protein Vif, which targets the relevant APOBEC3s for proteasomal degradation. While APOBEC3B does not restrict HIV-1 and is not targeted by HIV-1 Vif in CD4-positive T cells, we asked whether related lentiviral Vif proteins could degrade APOBEC3B. Interestingly, several SIV Vif proteins are capable of promoting APOBEC3B degradation, with SIVmac239 Vif proving the most potent. This likely occurs through the canonical polyubiquitination mechanism as APOBEC3B protein levels are restored by MG132 treatment and by altering a conserved E3 ligase-binding motif. We further show that SIVmac239 Vif can prevent APOBEC3B mediated geno/cytotoxicity and degrade endogenous APOBEC3B in several cancer cell lines. Our data indicate that the APOBEC3B degradation potential of SIV Vif is an effective tool for neutralizing the cancer genomic DNA deaminase APOBEC3B. Further optimization of this natural APOBEC3 antagonist may benefit cancer therapy

Measurement of the radiative capture cross section of the s-process branching points 204Tl and 171Tm at the n-TOF facility (CERN)

The neutron capture cross section of some unstable nuclei is especially relevant for s-process nucleosynthesis studies. This magnitude is crucial to determine the local abundance pattern, which can yield valuable information of the s-process stellar environment. In this work we describe the neutron capture (n,γ) measurement on two of these nuclei of interest, 204Tl and 171Tm, from target production to the final measurement, performed successfully at the n_TOF facility at CERN in 2014 and 2015. Preliminary results on the ongoing experimental data analysis will also be shown. These results include the first ever experimental observation of capture resonances for these two nuclei.The authors acknowledge financial support by the Spanish FPA2014-52823-C2-2-P project, by the EC Marie Curie Action “NeutAndalus” (FP7-PEOPLE-2012-CIG- 334315), by the ARGOS scholarship of the Spanish Nuclear Safety Council (CSN) and the Universitat Politècnica de Catalunya, and by the University of Sevilla via the VI PPIT-US program

A Retrospective Survey of HIV Drug Resistance Among Patients 1 Year After Initiation of Antiretroviral Therapy at 4 Clinics in Malawi

In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limited treatment options, population-level surveillance of acquired human immunodeficiency virus drug resistance (HIVDR) is critical to ensuring long-term treatment success. The World Health Organization target for clinic-level HIVDR prevention at 12 months after ART initiation is ≥ 70%. In 2007, viral load and HIVDR genotyping was performed in a retrospective cohort of 596 patients at 4 ART clinics. Overall, HIVDR prevention (using viral load ≤ 400 copies/mL) was 72% (95% confidence interval [CI], 67%-77%; range by site, 60%-83%) and detected HIVDR was 3.4% (95% CI, 1.8%-5.8%; range by site, 2.5%-4.7%). Results demonstrate virological suppression and HIVDR consistent with previous reports from sub-Saharan Africa. High rates of attrition because of loss to follow-up were noted and merit attention

Upgrades Of the SPS, Transfer Line and LHC Injection Protection Devices For the HL-LHC Era

The challenging High Luminosity LHC (HL-LHC) beam requirements will lead in the future to unprecedented beam parameters along the LHC injector chain. In the SPS accelerator these requests translate into about a factor two higher intensity and brightness than the present design performance. In addition to the challenge of producing and accelerating such beams, these parameters affect the resistance of the existing equipment against beam impact. Most of the protection devices in the SPS ring, its transfer lines and the LHC injection areas will be put under operational constraints which are beyond their design specification. The equipment concerned has been reviewed and their resistance to the HL-LHC beams checked. Theoretical and simulation studies have been performed for the SPS beam scraping system, the protection devices and the dump absorbers of the SPS-to-LHC transfer lines, as well as for the LHC injection protection devices. The first results of these studies are reported, together with the future prospects.Comment: 3 p. Presented at 4th International Particle Accelerator Conference (IPAC 2013

RNA editing signature during myeloid leukemia cell differentiation

Adenosine deaminases acting on RNA (ADARs) are key proteins for hematopoietic stem cell self-renewal and for survival of differentiating progenitor cells. However, their specific role in myeloid cell maturation has been poorly investigated. Here we show that ADAR1 is present at basal level in the primary myeloid leukemia cells obtained from patients at diagnosis as well as in myeloid U-937 and THP1 cell lines and its expression correlates with the editing levels. Upon phorbol-myristate acetate or Vitamin D3/granulocyte macrophage colony-stimulating factor (GM-CSF)-driven differentiation, both ADAR1 and ADAR2 enzymes are upregulated, with a concomitant global increase of A-to-I RNA editing. ADAR1 silencing caused an editing decrease at specific ADAR1 target genes, without, however, interfering with cell differentiation or with ADAR2 activity. Remarkably, ADAR2 is absent in the undifferentiated cell stage, due to its elimination through the ubiquitin–proteasome pathway, being strongly upregulated at the end of the differentiation process. Of note, peripheral blood monocytes display editing events at the selected targets similar to those found in differentiated cell lines. Taken together, the data indicate that ADAR enzymes play important and distinct roles in myeloid cells

Design, construction, and beam tests of a rotatable collimator prototype for high-intensity and high-energy hadron accelerators

A rotatable-jaw collimator design was conceived as a solution to recover from catastrophic beam impacts which would damage a collimator at the Large Hadron Collider (LHC) or its High-Luminosity upgrade (HL-LHC). One such rotatable collimator prototype was designed and built at SLAC and delivered to CERN for tests with LHC-type circulating beams in the Super Proton Synchrotron (SPS). This was followed by destructive tests at the dedicated High Radiation to Materials (HiRadMat) facility to validate the design and rotation functionality. An overview of the collimator design, together with results from tests without and with beam are presented

PARP1 catalytic variants reveal branching and chain length-specific functions of poly(ADP-ribose) in cellular physiology and stress response

Poly(ADP-ribosyl)ation regulates numerous cellular processes like genome maintenance and cell death, thus providing protective functions but also contributing to several pathological conditions. Poly(ADP-ribose) (PAR) molecules exhibit a remarkable heterogeneity in chain lengths and branching frequencies, but the biological significance of this is basically unknown. To unravel structure-specific functions of PAR, we used PARP1 mutants producing PAR of different qualities, i.e. short and hypobranched (PARP1\G972R), short and moderately hyperbranched (PARP1\Y986S), or strongly hyperbranched PAR (PARP1\Y986H). By reconstituting HeLa PARP1 knockout cells, we demonstrate that PARP1\G972R negatively affects cellular endpoints, such as viability, cell cycle progression and genotoxic stress resistance. In contrast, PARP1\Y986S elicits only mild effects, suggesting that PAR branching compensates for short polymer length. Interestingly, PARP1\Y986H exhibits moderate beneficial effects on cell physiology. Furthermore, different PARP1 mutants have distinct effects on molecular processes, such as gene expression and protein localization dynamics of PARP1 itself, and of its downstream factor XRCC1. Finally, the biological relevance of PAR branching is emphasized by the fact that branching frequencies vary considerably during different phases of the DNA damage-induced PARylation reaction and between different mouse tissues. Taken together, this study reveals that PAR branching and chain length essentially affect cellular functions, which further supports the notion of a ‘PAR code’